HEADER HYDROLASE 03-SEP-10 3OQP TITLE CRYSTAL STRUCTURE OF A PUTATIVE ISOCHORISMATASE (BXE_A0706) FROM TITLE 2 BURKHOLDERIA XENOVORANS LB400 AT 1.22 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE ISOCHORISMATASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BURKHOLDERIA XENOVORANS; SOURCE 3 ORGANISM_TAXID: 266265; SOURCE 4 STRAIN: LB400; SOURCE 5 GENE: BXENO_A3690, BXE_A0706; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS CATALYTIC TRIAD, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL KEYWDS 2 GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 5 01-FEB-23 3OQP 1 REMARK SEQADV LINK REVDAT 4 25-OCT-17 3OQP 1 REMARK REVDAT 3 12-NOV-14 3OQP 1 HET HETATM HETNAM HETSYN REVDAT 3 2 1 LINK MODRES SEQRES REVDAT 2 20-JUL-11 3OQP 1 KEYWDS REVDAT 1 13-OCT-10 3OQP 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF A PUTATIVE ISOCHORISMATASE (BXE_A0706) JRNL TITL 2 FROM BURKHOLDERIA XENOVORANS LB400 AT 1.22 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.22 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0110 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.22 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.57 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 99237 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.141 REMARK 3 R VALUE (WORKING SET) : 0.140 REMARK 3 FREE R VALUE : 0.166 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4954 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.22 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.25 REMARK 3 REFLECTION IN BIN (WORKING SET) : 6970 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.07 REMARK 3 BIN R VALUE (WORKING SET) : 0.2490 REMARK 3 BIN FREE R VALUE SET COUNT : 366 REMARK 3 BIN FREE R VALUE : 0.2650 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3119 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 15 REMARK 3 SOLVENT ATOMS : 481 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.39 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.24000 REMARK 3 B22 (A**2) : -2.11000 REMARK 3 B33 (A**2) : 1.40000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.70000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.042 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.037 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.965 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.980 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.972 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3432 ; 0.018 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2229 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4720 ; 1.776 ; 1.935 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5435 ; 1.028 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 469 ; 6.230 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 157 ;38.854 ;23.185 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 499 ;11.644 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;18.909 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 538 ; 0.111 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4037 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 737 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2208 ; 1.827 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 885 ; 1.241 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3577 ; 2.478 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1224 ; 3.322 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1132 ; 4.581 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 5659 ; 1.689 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 490 ; 9.713 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 5566 ; 6.295 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 5. PEG-200 (PG4) MOLECULES FROM THE REMARK 3 CRYOPROTECTION SOLUTION ARE MODELED. REMARK 4 REMARK 4 3OQP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-SEP-10. REMARK 100 THE DEPOSITION ID IS D_1000061453. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-FEB-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837,0.97937,0.97898 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 MONOCHROMATOR (HORIZONTAL REMARK 200 FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 99282 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.220 REMARK 200 RESOLUTION RANGE LOW (A) : 29.574 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.22 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.44400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: DATA WERE SCALED USING XSCALE WITH FRIEDEL PAIRS KEPT AS REMARK 200 SEPARATE WHEN COMPUTING R-SYM, COMPLETENESS AND REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20.0% POLYETHYLENE GLYCOL 3000, 0.15M REMARK 280 SODIUM CHLORIDE, 0.1M HEPES PH 7.9, NANODROP, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 51.56750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: ANALYTICAL SIZE EXCLUSION CHROMATOGRAPHY SUPPORTS THE REMARK 300 ASSIGNMENT OF A DIMER AS A SIGNIFICANT OLIGOMERIZATION STATE IN REMARK 300 SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15240 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 THR A 209 REMARK 465 ALA A 210 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 465 ALA B 210 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 207 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NE2 GLN A 186 OG SER B 31 2546 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 38 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 ARG A 38 NE - CZ - NH2 ANGL. DEV. = -4.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 120 -83.86 -131.65 REMARK 500 ARG A 171 -36.42 -159.21 REMARK 500 ASN B 120 -85.93 -128.12 REMARK 500 ARG B 171 -34.34 -160.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PG4 A 302 REMARK 610 PG4 B 301 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 399144 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS CONSTRUCT WAS EXPRESSED WITH AN N-TERMINAL PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3OQP A 1 210 UNP Q13UL1 Q13UL1_BURXL 1 210 DBREF 3OQP B 1 210 UNP Q13UL1 Q13UL1_BURXL 1 210 SEQADV 3OQP GLY A 0 UNP Q13UL1 EXPRESSION TAG SEQADV 3OQP GLY B 0 UNP Q13UL1 EXPRESSION TAG SEQRES 1 A 211 GLY MSE THR THR PRO ARG ARG ALA LEU ILE VAL ILE ASP SEQRES 2 A 211 VAL GLN ASN GLU TYR VAL THR GLY ASP LEU PRO ILE GLU SEQRES 3 A 211 TYR PRO ASP VAL GLN SER SER LEU ALA ASN ILE ALA ARG SEQRES 4 A 211 ALA MSE ASP ALA ALA ARG ALA ALA GLY VAL PRO VAL VAL SEQRES 5 A 211 ILE VAL GLN ASN PHE ALA PRO ALA GLY SER PRO LEU PHE SEQRES 6 A 211 ALA ARG GLY SER ASN GLY ALA GLU LEU HIS PRO VAL VAL SEQRES 7 A 211 SER GLU ARG ALA ARG ASP HIS TYR VAL GLU LYS SER LEU SEQRES 8 A 211 PRO SER ALA PHE THR GLY THR ASP LEU ALA GLY TRP LEU SEQRES 9 A 211 ALA ALA ARG GLN ILE ASP THR LEU THR VAL THR GLY TYR SEQRES 10 A 211 MSE THR HIS ASN CSD ASP ALA SER THR ILE ASN HIS ALA SEQRES 11 A 211 VAL HIS SER GLY LEU ALA VAL GLU PHE LEU HIS ASP ALA SEQRES 12 A 211 THR GLY SER VAL PRO TYR GLU ASN SER ALA GLY PHE ALA SEQRES 13 A 211 SER ALA GLU GLU ILE HIS ARG VAL PHE SER VAL VAL LEU SEQRES 14 A 211 GLN SER ARG PHE ALA ALA VAL ALA SER THR ASP GLU TRP SEQRES 15 A 211 ILE ALA ALA VAL GLN GLY GLY THR PRO LEU ALA ARG GLY SEQRES 16 A 211 ASN ILE TYR ALA SER ASN GLN LYS ALA ARG ALA ARG ARG SEQRES 17 A 211 ALA THR ALA SEQRES 1 B 211 GLY MSE THR THR PRO ARG ARG ALA LEU ILE VAL ILE ASP SEQRES 2 B 211 VAL GLN ASN GLU TYR VAL THR GLY ASP LEU PRO ILE GLU SEQRES 3 B 211 TYR PRO ASP VAL GLN SER SER LEU ALA ASN ILE ALA ARG SEQRES 4 B 211 ALA MSE ASP ALA ALA ARG ALA ALA GLY VAL PRO VAL VAL SEQRES 5 B 211 ILE VAL GLN ASN PHE ALA PRO ALA GLY SER PRO LEU PHE SEQRES 6 B 211 ALA ARG GLY SER ASN GLY ALA GLU LEU HIS PRO VAL VAL SEQRES 7 B 211 SER GLU ARG ALA ARG ASP HIS TYR VAL GLU LYS SER LEU SEQRES 8 B 211 PRO SER ALA PHE THR GLY THR ASP LEU ALA GLY TRP LEU SEQRES 9 B 211 ALA ALA ARG GLN ILE ASP THR LEU THR VAL THR GLY TYR SEQRES 10 B 211 MSE THR HIS ASN CSD ASP ALA SER THR ILE ASN HIS ALA SEQRES 11 B 211 VAL HIS SER GLY LEU ALA VAL GLU PHE LEU HIS ASP ALA SEQRES 12 B 211 THR GLY SER VAL PRO TYR GLU ASN SER ALA GLY PHE ALA SEQRES 13 B 211 SER ALA GLU GLU ILE HIS ARG VAL PHE SER VAL VAL LEU SEQRES 14 B 211 GLN SER ARG PHE ALA ALA VAL ALA SER THR ASP GLU TRP SEQRES 15 B 211 ILE ALA ALA VAL GLN GLY GLY THR PRO LEU ALA ARG GLY SEQRES 16 B 211 ASN ILE TYR ALA SER ASN GLN LYS ALA ARG ALA ARG ARG SEQRES 17 B 211 ALA THR ALA MODRES 3OQP MSE A 1 MET SELENOMETHIONINE MODRES 3OQP MSE A 40 MET SELENOMETHIONINE MODRES 3OQP MSE A 117 MET SELENOMETHIONINE MODRES 3OQP CSD A 121 CYS 3-SULFINOALANINE MODRES 3OQP MSE B 40 MET SELENOMETHIONINE MODRES 3OQP MSE B 117 MET SELENOMETHIONINE MODRES 3OQP CSD B 121 CYS 3-SULFINOALANINE HET MSE A 1 8 HET MSE A 40 8 HET MSE A 117 8 HET CSD A 121 8 HET MSE B 40 8 HET MSE B 117 8 HET CSD B 121 8 HET PG4 A 302 7 HET CL B 300 1 HET PG4 B 301 7 HETNAM MSE SELENOMETHIONINE HETNAM CSD 3-SULFINOALANINE HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM CL CHLORIDE ION HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE FORMUL 1 MSE 5(C5 H11 N O2 SE) FORMUL 1 CSD 2(C3 H7 N O4 S) FORMUL 3 PG4 2(C8 H18 O5) FORMUL 4 CL CL 1- FORMUL 6 HOH *481(H2 O) HELIX 1 1 GLN A 14 VAL A 18 5 5 HELIX 2 2 ASP A 28 GLY A 47 1 20 HELIX 3 3 SER A 68 GLU A 72 5 5 HELIX 4 4 HIS A 74 GLU A 79 1 6 HELIX 5 5 ASP A 98 ALA A 105 1 8 HELIX 6 6 ASN A 120 SER A 132 1 13 HELIX 7 7 SER A 156 PHE A 172 1 17 HELIX 8 8 SER A 177 GLY A 188 1 12 HELIX 9 9 ASN A 195 ALA A 208 1 14 HELIX 10 10 GLN B 14 VAL B 18 5 5 HELIX 11 11 ASP B 28 GLY B 47 1 20 HELIX 12 12 HIS B 74 GLU B 79 1 6 HELIX 13 13 ASP B 98 ARG B 106 1 9 HELIX 14 14 ASN B 120 GLY B 133 1 14 HELIX 15 15 SER B 156 PHE B 172 1 17 HELIX 16 16 SER B 177 GLY B 188 1 12 HELIX 17 17 ASN B 195 ALA B 205 1 11 HELIX 18 18 ARG B 206 ALA B 208 5 3 SHEET 1 A 6 HIS A 84 LYS A 88 0 SHEET 2 A 6 VAL A 50 ASN A 55 1 N ILE A 52 O HIS A 84 SHEET 3 A 6 ARG A 6 ILE A 11 1 N LEU A 8 O VAL A 51 SHEET 4 A 6 THR A 110 TYR A 116 1 O THR A 112 N ALA A 7 SHEET 5 A 6 ALA A 135 GLY A 144 1 O GLU A 137 N VAL A 113 SHEET 6 A 6 ALA A 174 ALA A 176 1 O ALA A 174 N PHE A 138 SHEET 1 B 2 TYR A 148 ASN A 150 0 SHEET 2 B 2 GLY A 153 ALA A 155 -1 O ALA A 155 N TYR A 148 SHEET 1 C 6 HIS B 84 LYS B 88 0 SHEET 2 C 6 VAL B 50 ASN B 55 1 N ILE B 52 O HIS B 84 SHEET 3 C 6 ARG B 6 ILE B 11 1 N VAL B 10 O VAL B 51 SHEET 4 C 6 THR B 110 TYR B 116 1 O THR B 112 N ILE B 9 SHEET 5 C 6 ALA B 135 GLY B 144 1 O GLU B 137 N VAL B 113 SHEET 6 C 6 ALA B 174 ALA B 176 1 O ALA B 174 N PHE B 138 SHEET 1 D 2 TYR B 148 ASN B 150 0 SHEET 2 D 2 GLY B 153 ALA B 155 -1 O GLY B 153 N ASN B 150 LINK C MSE A 1 N THR A 2 1555 1555 1.33 LINK C ALA A 39 N MSE A 40 1555 1555 1.33 LINK C MSE A 40 N ASP A 41 1555 1555 1.34 LINK C TYR A 116 N MSE A 117 1555 1555 1.34 LINK C MSE A 117 N THR A 118 1555 1555 1.33 LINK C ASN A 120 N CSD A 121 1555 1555 1.32 LINK C CSD A 121 N ASP A 122 1555 1555 1.29 LINK C ALA B 39 N MSE B 40 1555 1555 1.34 LINK C MSE B 40 N ASP B 41 1555 1555 1.32 LINK C TYR B 116 N MSE B 117 1555 1555 1.33 LINK C MSE B 117 N THR B 118 1555 1555 1.32 LINK C ASN B 120 N CSD B 121 1555 1555 1.31 LINK C CSD B 121 N ASP B 122 1555 1555 1.34 CISPEP 1 TYR A 26 PRO A 27 0 -11.35 CISPEP 2 TYR A 116 MSE A 117 0 -10.60 CISPEP 3 TYR B 26 PRO B 27 0 -11.13 CISPEP 4 TYR B 26 PRO B 27 0 -12.77 CISPEP 5 TYR B 116 MSE B 117 0 -17.42 SITE 1 AC1 12 ASN A 55 PHE A 64 LYS A 88 SER A 89 SITE 2 AC1 12 LEU A 90 PRO A 91 ASN A 120 CSD A 121 SITE 3 AC1 12 HOH A 349 HOH A 484 HOH A 632 HOH B 407 SITE 1 AC2 4 GLN A 169 ASN B 150 SER B 151 HOH B 751 SITE 1 AC3 3 ALA A 123 LEU A 168 ASN B 127 CRYST1 37.369 103.135 45.062 90.00 98.94 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026760 0.000000 0.004209 0.00000 SCALE2 0.000000 0.009696 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022464 0.00000 HETATM 1 N MSE A 1 13.852 6.312 8.691 1.00 33.98 N ANISOU 1 N MSE A 1 4409 4430 4068 45 -86 38 N HETATM 2 CA MSE A 1 13.685 7.037 9.994 1.00 33.29 C ANISOU 2 CA MSE A 1 4323 4327 3999 79 -84 85 C HETATM 3 C MSE A 1 14.282 6.260 11.172 1.00 29.72 C ANISOU 3 C MSE A 1 3839 3868 3584 99 -132 58 C HETATM 4 O MSE A 1 14.207 5.038 11.209 1.00 30.77 O ANISOU 4 O MSE A 1 4076 4029 3583 143 -189 55 O HETATM 5 CB MSE A 1 12.204 7.252 10.304 1.00 34.78 C ANISOU 5 CB MSE A 1 4387 4592 4233 91 -78 67 C HETATM 6 CG MSE A 1 11.598 8.529 9.735 1.00 41.43 C ANISOU 6 CG MSE A 1 5485 5244 5013 33 -74 128 C HETATM 7 SE MSE A 1 9.700 8.707 10.279 0.75 54.43 SE ANISOU 7 SE MSE A 1 6948 7546 6185 335 84 -85 SE HETATM 8 CE MSE A 1 9.181 6.799 10.220 1.00 52.52 C ANISOU 8 CE MSE A 1 6594 7102 6257 129 30 0 C